Literature DB >> 19171986

Immune reconstitution inflammatory syndrome.

Ajay Sharma1, Smita Makrandi, Megha Modi, Archana Sharma, Yogesh Marfatia.   

Abstract

BACKGROUND: Immune reconstitution inflammatory syndrome (IRIS) is a paradoxical deterioration in clinical status in a patient on antiretroviral treatment (ART) despite satisfactory control of viral replication and improvement of CD4 count. AIM: To study development of IRIS as a part of ART.
METHODS: Hundred patients on antiretroviral treatment were studied prospectively in the Department of Skin and VD over a period of 2 years. Patients were asked to come if they developed any symptoms or on a monthly basis. They were screened clinically and investigated suitably for evidence of opportunistic infections.
RESULTS: Out of 100 patients, 10 patients did not come for follow-up. Twenty (22.2%) out of the 90 patients developed IRIS. Herpes zoster (HZ), herpes simplex virus (HSV), and tuberculosis (TB) were the cases of IRIS seen in the present study.
CONCLUSIONS: IRIS in terms of HSV/TB is known to accelerate HIV disease progression. Hence early detection and prompt treatment, along with continuation of highly active ART, are of utmost importance.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19171986     DOI: 10.4103/0378-6323.45105

Source DB:  PubMed          Journal:  Indian J Dermatol Venereol Leprol        ISSN: 0378-6323            Impact factor:   2.545


  4 in total

Review 1.  Immune reconstitution inflammatory syndrome in patients starting antiretroviral therapy for HIV infection: a systematic review and meta-analysis.

Authors:  Monika Müller; Simon Wandel; Robert Colebunders; Suzanna Attia; Hansjakob Furrer; Matthias Egger
Journal:  Lancet Infect Dis       Date:  2010-04       Impact factor: 25.071

Review 2.  Looking back to move forward: a twenty-year audit of herpes zoster in Asia-Pacific.

Authors:  Liang-Kung Chen; Hidenori Arai; Liang-Yu Chen; Ming-Yueh Chou; Samsuridjal Djauzi; Birong Dong; Taro Kojima; Ki Tae Kwon; Hoe Nam Leong; Edward M F Leung; Chih-Kuang Liang; Xiaohong Liu; Dilip Mathai; Jiun Yit Pan; Li-Ning Peng; Eduardo Rommel S Poblete; Philip J H Poi; Stewart Reid; Terapong Tantawichien; Chang Won Won
Journal:  BMC Infect Dis       Date:  2017-03-15       Impact factor: 3.090

3.  Effects of highly active antiretroviral therapy and its adherence on herpes zoster incidence: a longitudinal cohort study.

Authors:  Chenglong Liu; Cuiwei Wang; Marshall J Glesby; Gypsyamber D'souza; Audrey French; Howard Minkoff; Toby Maurer; Roksana Karim; Mary Young
Journal:  AIDS Res Ther       Date:  2013-12-27       Impact factor: 2.250

4.  Correlating CD4 count with mucocutaneous manifestations in HIV-positive patients: A prospective study.

Authors:  C Chandrakala; K Parimalam; Afthab Jameela Wahab; N Anand
Journal:  Indian J Sex Transm Dis AIDS       Date:  2017 Jul-Dec
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.